A collaborative design NGS panel targeting clinically actionable mutations across cancer types. Designed to identify mutations with therapeutic implications for treatment guidance. Available as a pre-designed panel for immediate implementation.
Manufactured by
Nonacus
United Kingdom
Nonacus is a UK-based leader in precision oncology, transforming how cancer is detected and managed. Headquartered in Birmingham and working with scientists and clinicians worldwide, we are building an end-to-end genetic testing workflow designed to make early cancer detection simpler, faster, and more accessible.
© 2026 Suplivia · Home · Browse Products